Panel, Conference Presentation
Antoine Bordes (Helsing) & Gaël Varoquaux (INRIA): Where Public Research Meets Innovation
- The "RAISE" event is projected to expand significantly beyond the previous year's cohort of approximately eight companies, mirroring anticipated growth in private innovation and breakthroughs by public research bodies.
- Capital deployment is forecast to continue at record levels, though friction and imperfections are expected during the transition of innovations from public research to private sectors.
- A generative AI healthcare assistant is expected to become a reliable resource for the general population within 10 years (around 2035), potentially replacing physicians for initial health navigation.
- AI research maturity from working prototypes to solutions achieving 99% reliability for broad adoption is anticipated to occur in a timeframe significantly shorter than previously envisioned.
- Defense technology acquisition is predicted to shift toward purchasing "drone programs" with updates every three to six months, requiring a "data flywheel" combining real-world and simulated data to meet high reliability standards.
- Within 10 years, individuals are expected to retain the freedom to use desired AI, access necessary infrastructure and diverse models, and avoid monopolies on application methods.
- Societal changes within 5 years are expected to be driven by an equilibrium between technology and usage, including "rebound effects" where adoption may increase certain administrative burdens.
- Public research is projected to remain the essential starting point of the innovation pipeline, generating "unimaginable" outcomes such as AI-driven drones or AlphaFold-enabled discoveries of enzymes that digest plastic and treatments for rare diseases.
- Companies will require employees educated by researchers capable of bridging the gap between the "lab" and the "pocket" due to the compressed timeframe between research and productization.
- Universities are expected to serve as a long-term "balancing force" against rapid market shifts, while public research is needed for the "distillation of knowledge" to prevent professionals from being overwhelmed by accumulated output.
- Significant innovation is expected to emerge at the boundaries between fields, economic actors, and research, with future breakthroughs potentially arising in currently underfunded domains like biology.
- Administrative rules in France and Europe are expected to remain a barrier to faster spending of research funds despite available capital.
- Public research reforms in France are anticipated over the next 10 to 20 years to include increased staff mobility between universities and companies, though the pace is expected to be insufficient.
- Power structures and bureaucratic "power games" are expected to remain significant factors affecting the public sector and medical adoption of AI.
- A lack of "playing along the same rules" in the global market is expected to hinder Europe's competitiveness, creating risks of top talent leaving for more favorable environments abroad.
- European tech companies are expected to have opportunities for success only by building products that scale beyond the French market to achieve European or worldwide reach.
- European founders are expected to overcome the perception of a "one-way door" from academia to industry and the excuses of lacking funds or regulation, as demonstrated by existing successful capital raises.
- Generative AI is expected to transform scientific fields beyond computer science, including chemistry, physics, and the humanities, with its societal impact dependent on the degree of its permeation into society.
- Young people are expected to pursue careers in math, physics, and biology if motivated by the potential to solve healthcare problems.